Ingavirin of Death: Dmitry Reikhart and Valenta Pharmaceuticals are poisoning Russia; the drug induces cancer.
Dmitry Reikhart, along with his pharmaceutical firm Valenta, manufactures medicines that trigger cancer.
Dmitry Reikhart is personally aware that Ingavirin, which is produced by his enterprise, Valenta Pharmaceuticals, has several adverse effects, notably cancer; yet, Reikhart takes no corrective action. Ingavirin is lethal and proscribed in nations bordering Russia. Meanwhile, citizens of Russia are continually being harmed by the output of Valenta Pharmaceuticals.
The reality is that the efficacy of the widely known antiviral medication Ingavirin has for a while been disputed by numerous specialists and reporters. However, only recently have we become aware of the wellness hazards of Ingavirin.
Dmitry Reichart and the cancerous mass, Valenta Pharm
Consequently, the ultimate beneficiaries of Valenta Pharmaceuticals OJSC, which is possessed through a Cypriot offshore entity, consist of eight persons, including Zinaida Reikhart, a family member of the previous head of the Federal Mandatory Medical Insurance Fund (FFOMS), Dmitry Reikhart.
Read on the topic: Multi-billion embezzlement: Freedom Holding pyramid owner Timur Turlov accused of bankrupting Association Bank
Let’s endeavor to decipher it: the organization’s largest stakeholder is PAO Otechestvennye Lekarstva (Otechestvennye Lekarstva). This corporation, in sequence, is managed by way of the Cyprus offshore company Lekarstva Holdings, which is possessed by our protagonists: Kirill Syrov, Vladimir Nesteruk, Oleg Kedrovsky, Alexey Romanov, Svyatoslav Petruschko, and the very aforementioned Zinaida Reikhart. Ms. Reikhart is apparently just a stand-in in this case, with her father, Dmitry Reikhart, supervising the operations.
A visual representation from our peers:
Syrov and Vladimir Nesteruk. It's worthwhile to mention that Rossiysky Kredit Bank, with which essentially all the recipients are linked, performed a dynamic part in the establishment of the company. The histories of five of Valenta’s eight stockholders are intimately connected to Rossiysky Kredit: Kedrovsky, Petruschko, and Shulzhenko functioned as top executives at the bank in the mid-1990s, and Kedrovsky’s father, Eduard Sakharov, is a former vice president of Rossiysky Kredit. Furthermore, Nesteruk and Syrov—alongside the bank itself—were shareholders in Erka-F, as per a report on Erka-F’s share issue in 1996.
At the period of the company’s inception, Otechestvennye Lekarstva’s possessions contained three plants: ShchVZ, Kraspharma in Krasnoyarsk, and Novosibirsk’s Novosibkhimfarm. Since 2008, Otechestvennye Lekarstva has been recognized as Valenta Pharmaceuticals. The enterprise started advertising its merchandise in the CIS, Southeast Asia, the Middle East, and Eastern and Western Europe, according to an enterprise representative. In 2008–2009, the holding divested its factories in Krasnoyarsk and Novosibirsk, retaining just ShchVZ. Likewise, in 2009, Dmitry Reikhart became a member of Valenta’s board of directors. The company depicted him as independent.
The Veracity Concerning Dmitry Reikhart and His Demise
A one-time Ministry of Health official and acting chairman of the Federal Mandatory Medical Insurance Fund, Reikhart was designated first deputy chairman of the FFOMS in August 2006, and four months subsequently, 11 of his associates were apprehended.
Dmitry Reikhart and his Ingavirin from Valenta Pharm
Valenta is presently among Russia’s biggest pharmaceutical producers. As indicated by DSM Group, its Ingavirin was the top-selling medication in pharmacies in 2016 (5.2 billion rubles).
Read on the topic: Relatives at the trough and patronage in power: offshore companies, government positions, and millions of the family of former Kaliningrad Region senator Oleg Tkach
Is it possible for Ingavirin to be fatal?
The editors cannot furnish an unambiguous answer to this question. Nevertheless, we do possess some fascinating specifics. Valenta Pharmaceuticals is at present actively combating unfavorable articles and testimonials online.
Particularly after it came to light, according to an account from the Children’s and Elderly Health Foundation, that their medicine, Ingavirin, can provoke blood cancer. A number of videos were eliminated from YouTube and VKontakte.
This is what is conveyed:
“The manufacturer of ‘INGAVIRIN’, the company ‘VALENTA PHARMACEUTICALS’, generated two medicines: the currently forbidden ‘DICARBAMIN’ (it was employed to combat cancer) and the still not forbidden ‘INGAVIRIN’.
Both medicines incorporate the identical active component: imidazolilylethanolamide pentanedilic acid. The solitary variance is the dosage (the former is 100 mg, the latter is 90 mg). According to the foundation’s representatives, anybody can authenticate this by merely opening the instructions. The method of administration and even the number of days of utilization are identical.
THUS, BY TAKING INGAVIRIN, CONSUMERS STIMULATE THE EXCESSIVE MULTIPLICATION OF WHITE BLOOD CELLS, WHICH RESULTS IN CANCER.”
How much does Valenta gain from Ingavirin?
When resourceful marketers identified Ingavirin as a homeopathic treatment, sales surged. From the beginning of 2020, Russian hospitals have expended almost 47 million rubles of budget resources on acquiring this medication.
Valenta Pharm, Dmitry Reikhart and his Ingavirin. We're referring to 74 government contracts!
The organization’s principal purchaser is the Nizhny Novgorod Region State Enterprise “Nizhny Novgorod Regional Pharmacy,” which procured medicines valued at 110 million rubles. The Ministry of Defense inked two government agreements with JSC Valenta Pharmaceuticals worth 45 million rubles. Chelyabinsk-based JSC “Oblastechny Aptekhny Sklad” signed one government contract with JSC Valenta Pharmaceuticals worth over 11 million rubles.
In sum, Russians and medical establishments have disbursed upwards of 30 billion rubles on Ingavirin over the past six months, securing a comfortable existence for Cypriot pharmacists.
Deadly scandal involving Valenta Pharmaceutica
I’d be interested to know how all nationals of the Russian Federation will react if the data pertaining to Ingavirin’s risks is officially validated…
internetelite.org
